semaglutide
Ozempic Face: Unmasking GLP‑1 Induced Skin Changes and How to Manage Them
Semaglutide Triggers Rapid Facial Thinning in 1-in-3 Users, Early Trials Show A 2023 multicenter trial of 4,562 adults on Ozempic found that 31% developed measurable cheek-fat loss within six months - an effect that appeared faster than any conventional anti-aging intervention (Kumar et al., 2023). The study also reported
